William Pao - Researcher Profile | RDL Research Database

Publications

2 shown

Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer

Vincent A. Miller , Mark G. Kris , Neelam Shah +14 more

Purpose Gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, induces radiographic regressions and symptomatic improvement in patients with non–small-...

2004 Journal of Clinical Oncology 744 citations

EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib

William Pao , Vincent A. Miller , Maureen F. Zakowski +12 more

Somatic mutations in the tyrosine kinase (TK) domain of the epidermal growth factor receptor (EGFR) gene are reportedly associated with sensitivity of lung cancers to gefitinib ...

2004 Proceedings of the National Academy o... 4316 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 5,060
Institution: Memorial Sloan Kettering Cancer Center

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.